Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. (Q33378992)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.
scientific article

    Statements

    title
    Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    18347182
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18347182%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    4 January 2020
    author

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q33378992&oldid=1855147169"